Lung adenocarcinoma

There are 131 papers on lung adenocarcinoma in aging research: 3 trials and 50 observational studies in people, 30 in animals, 17 in cells, 9 reviews. The newest story, Nov 6, 2026: “Blood-cell mutations linked to two solid cancer subtypes”.

Disease

131 papers study it24 more mention it31 findings

10 new papers in 30 daysSee all 155 papers on lung adenocarcinoma

At a glance

Human data link early-stage lung adenocarcinoma to lower urinary miR-574-5p and associate it with an increasing lung cancer trend from 2001 to 2020. An in silico preprint estimates that annual lifetime low-dose CT screening averts deaths in never-smoking Asian women compared with no screening.

31 findings in 27 papers from 2003 to 2026, 12 of them since May 2026

“distinguished malignant from benign pulmonary nodules with areas under the curve (AUC) values of 0.87-0.89”
An All-in-Tip Accelerated Proteomics Platform for Large-Scale Cancer ScreeningAnalytical chemistry2026doi:10.1021/acs.analchem.5c06612
  • Human trial3
  • Humans50
  • Animals30
  • Cells17
  • In silico19

Interventions

4

Haemophilus parainfluenzae

downin humans1

1 study
  1. Haemophilus parainfluenzae is linked with less lung adenocarcinoma in humans (Mendelian randomization using European-origin GWAS summary data).

    “Haemophilus parainfluenzae protected against lung adenocarcinoma”

    HumansMendelian randomization using European-origin GWAS summary data

    Causal relationship between oral microbiome, circulating inflammatory proteins and lung cancer: A Mendelian randomization study

    Medicine

More on Haemophilus parainfluenzae

Low-dose computed tomography screening

downin silico1

1 study
  1. Low-dose computed tomography screening decreases lung adenocarcinoma in silico (annual LDCT over lifetime compared with no screening in never-smoking Asian women) (14,940 deaths averted).

    “Over a lifetime, annual LDCT averted 8,534 lung adenocarcinoma deaths compared with annual CXR and 14,940 deaths compared with no screening.”

    In silicoannual LDCT over lifetime compared with no screening in never-smoking Asian womenlifetimefemales

    Optimal LDCT screening for never-smoking Asian women using integrated polygenic and environmental risk: a microsimulation modelling study

    medRxivPreprint

More on Low-dose computed tomography screening

Mek inhibitor

downin mice1

1 study
  1. Mek inhibitor decreases lung adenocarcinoma in Eif4a2 knockout tumours with enhanced MAP-kinase signalling.

    “in contrast to eIF4A2+/+ lesions, these were eradicated by administration of a MEK inhibitor”

    Animalsin Eif4a2 knockout tumours with enhanced MAP-kinase signallinglung

    Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer

    Molecular cancer

More on Mek inhibitor

Acetylcysteine

upin mice1

1 study
  1. Acetylcysteine induces lung adenocarcinoma in mice (JunD-deficient and aged control mice) (50% of JunD-deficient mice, 10% of aged control mice).

    “but concomitantly induced the development of lung adenocarcinoma in 50% of JunD-deficient mice and 10% of aged control mice”

    AnimalsJunD-deficient and aged control micelung

    The antioxidant N-acetylcysteine protects from lung emphysema but induces lung adenocarcinoma in mice

    JCI insight

More on Acetylcysteine

Effects

3

Lung cancer

upin humans1

1 study
  1. Lung adenocarcinoma is linked with higher lung cancer in humans (temporal trend 2001 to 2020) (AAPC=35.1, 95% CI 14.2-50.2).

    “Joinpoint regression analysis demonstrated a consistent long-term increase in adenocarcinoma (AAPC=35.1, 95% CI 14.2-50.2)”

    Humanstemporal trend 2001 to 2020lung2001 to 2020

    Temporal Trends in Lung Cancer and Histological Subtype Incidence and Bayesian Projections to 2030 in China: Population-Based Quantitative Study

    JMIR public health and surveillance

More on Lung cancer

miR-574-5p

downin humans1

1 study
  1. Lung adenocarcinoma is linked with lower miR-574-5p in humans (early-stage lung adenocarcinoma (stage 0-IA2)).

    “Urinary miR-574-5p expression was significantly decreased in patients with early-stage adenocarcinoma”

    Humansearly-stage lung adenocarcinoma (stage 0-IA2)urinen = 77

    Urinary miR-574-5p as a candidate biomarker for early-stage lung adenocarcinoma: an exploratory case-control study

    Translational lung cancer research

More on miR-574-5p

Epigenetic age

upin humans1

1 study
  1. Lung adenocarcinoma is linked with higher epigenetic age in tumour subclones of primary lung adenocarcinoma.

    “we demonstrated accelerated epigenetic ageing and mitotic activity in tumour subclones, providing new insights into tumorigenesis”

    Humansin tumour subclones of primary lung adenocarcinoma

    High-throughput single-cell DNA methylation and chromatin accessibility co-profiling with SpliCOOL-seq

    Clinical and translational medicine

More on Epigenetic age

Upstream

3

IL-1 signaling

upin reviews1

1 study
  1. IL-1 signaling increases lung adenocarcinoma (EGFR-mutant lung adenocarcinoma).

    “macrophage-derived interleukin-1β (IL-1β) signaling, which promotes epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma.”

    ReviewEGFR-mutant lung adenocarcinomalung

    Environmental PM2.5 exposure associated with lung cancer in nonsmokers: a narrative review of high-risk groups, mechanisms, and implications for screening

    Journal of toxicology and environmental health. Part B, Critical reviews

More on IL-1 signaling

SPOCD1

mediatesin human cells1

1 study
  1. SPOCD1 mediates lung adenocarcinoma in human cells (rescue experiments).

    “Rescue experiments confirmed that SPOCD1 mediates POU2F2's oncogenic effects.”

    Cellsrescue experiments

    Exercise inhibits proliferation and induces apoptosis of lung adenocarcinoma cells via the POU2F2-SPOCD1-PI3K/AKT signaling axis

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

More on SPOCD1

CXCL16+ macrophage

upin humans1

1 study
  1. CXCL16+ macrophage increases lung adenocarcinoma in humans (via TGF-β signalling).

    “Functionally, CXCL16+ macrophages promoted LUAD progression via TGF-β signalling, as validated in vitro and in subcutaneous and orthotopic tumour models.”

    Animalsvia TGF-β signalling

    Multiomics analysis reveals that senescent CXCL16⁺ macrophages promote lung adenocarcinoma progression through TGF-β signalling

    Journal of translational medicine

Associations

18

Telomere length

upin humans4OR 1.88–2.43

4 studies
  1. Telomere length is linked with a higher risk of lung adenocarcinoma in humans after removing outlier SNPs in radial MR (OR 1.88, 95% CI 1.25-2.82).

    “significant associations were identified for both lung adenocarcinoma [OR, 1.88 (95% CI, 1.25-2.82)] and lung squamous cell carcinoma (2.29, 1.05-4.98)”

    Humansafter removing outlier SNPs in radial MR

    The Causal Relationship between Telomere Length and Cancer Risk: A Two-Sample Mendelian Randomization

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

  2. Telomere length is linked with a higher risk of lung adenocarcinoma in humans.

    “longer LTL conferred an increased risk of lung cancer regardless of smoking status in the MR analyses, particularly for lung adenocarcinoma”

    Humans

    Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome

    eLife

  3. Telomere length is linked with a higher risk of lung adenocarcinoma in humans (OR=2.43, 95%CI=2.02-2.92, p=3.8×10 −21).

    “and lung adenocarcinoma (OR=2.43, 95%CI=2.02-2.92, p=3.8×10 −21 ).”

    Humans

    Common genetic variations in telomere length genes and lung cancer

    medRxivPreprint

  4. Telomere length raises the risk of lung adenocarcinoma in humans (adenocarcinomas) (OR 1.98, 95% CI 1.69-2.31).

    “The effect was even more evident for adenocarcinomas (OR 1.98, 95% CI 1.69-2.31)”

    Reviewadenocarcinomas

    Leucocyte Telomere Length and Lung Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies

    Cancers

More on Telomere length

Clonal hematopoiesis of indeterminate potential

upin humans1HR 1.79

1 study
  1. Clonal hematopoiesis of indeterminate potential is associated with lung adenocarcinoma in humans (UK Biobank participants without pre-baseline cancer) (HR 1.79, 95% CI 1.48–2.16).

    “Among 17 endpoints, two survived multiple testing correction: lung adenocarcinoma (HR, 1.79; 95% CI, 1.48 - 2.16)”

    HumansUK Biobank participants without pre-baseline cancer

    Blood-cell mutations linked to two solid cancer subtypes

    medRxivPreprint

More on Clonal hematopoiesis of indeterminate potential

ANGPTL4

upin humans1

1 study
  1. Lung adenocarcinoma is associated with ANGPTL4 in humans (lung adenocarcinoma).

    “We found that ANGPTL4 protein levels were increased in LUAD tissues.”

    Humanslung adenocarcinomalung adenocarcinoma tissue

    Senescence-Related Transcriptomic Analysis and Functional Characterization of ANGPTL4 in Lung Adenocarcinoma

    Cancers

More on ANGPTL4

Sea salt

upin humans1HR 1.04

1 study
  1. Sea salt is associated with lung adenocarcinoma in humans (mixture model) (HR 1.04, 95% CI 1.01–1.07).

    “sea salt (HR = 1.04 [1.01–1.07]) were associated with adenocarcinoma”

    Humansmixture modelper interquartile range2010–2018n = 364,842

    Outdoor PM2.5 Chemical Components and Risk of Lung Cancer in a Large Prospective U.S. Cohort

    Environmental health perspectives

More on Sea salt

Nitrogen dioxide

upin humans1HR 1.08

1 study
  1. Nitrogen dioxide is associated with lung adenocarcinoma in humans (mixture model) (HR 1.08, 95% CI 1.03–1.13).

    “NO2 (HR = 1.08 [1.03–1.13]) and sea salt (HR = 1.04 [1.01–1.07]) were associated with adenocarcinoma”

    Humansmixture modelper interquartile range2010–2018n = 364,842

    Outdoor PM2.5 Chemical Components and Risk of Lung Cancer in a Large Prospective U.S. Cohort

    Environmental health perspectives

More on Nitrogen dioxide

MAPK/ERK signaling

upin mice1

1 study
  1. Lung adenocarcinoma is associated with MAPK/ERK signaling in mice (Spontaneous lung papillary adenocarcinoma).

    “RNA sequencing indicated activation of the MAPK pathway in the lung tumor”

    AnimalsSpontaneous lung papillary adenocarcinomaLung tumorn = 1

    Analysis of spontaneous tumors in C57BL/6JJcl mice with frequent malignant lymphomas and a Braf-mutant lung adenocarcinoma

    Journal of Toxicologic Pathology

More on MAPK/ERK signaling

S100-A12

upin humans1

1 study
  1. S100-A12 is linked with a higher risk of lung adenocarcinoma in humans (Mendelian randomization using European-origin GWAS summary data).

    “the protein S100-A12 elevated adenocarcinoma risk”

    HumansMendelian randomization using European-origin GWAS summary data

    Causal relationship between oral microbiome, circulating inflammatory proteins and lung cancer: A Mendelian randomization study

    Medicine

More on S100-A12

Smoking intensity

upin humans1OR 2.66

1 study
  1. Smoking intensity is linked with a higher risk of lung adenocarcinoma in humans (OR 2.66, 95% CI 1.40–5.06).

    “adenocarcinoma (OR: 2.66, 95% CI: 1.40-5.06)”

    Humansper standard deviation increase in cigarettes smoked per dayn = 571

    Contributions of smoking behaviour to lung cancer subtypes: A two-sample Mendelian randomization study

    Medicine

More on Smoking intensity

Ten-metabolite diagnostic assay

upin humans1

1 study
  1. Ten-metabolite diagnostic assay predicts lung adenocarcinoma in humans (overall LUAD cohort) (AUC 0.900).

    “we develop a ten-metabolite diagnostic assay that demonstrates reproducible performance across independent cohorts (area under the curve 0.900 for overall; 0.860 for pre-invasive disease).”

    Humansoverall LUAD cohortfemalesn = 2,836

    A high-resolution circulating metabolic atlas of lung adenocarcinoma progression supports early and accurate diagnosis

    Cell reports. Medicine

More on Ten-metabolite diagnostic assay

miR-574-5p

downin humans1OR 0.15

1 study
  1. miR-574-5p is associated with lung adenocarcinoma in humans (adjusted for age, sex, smoking status, and urinary creatinine) (OR 0.15, 95% CI: 0.02-0.53).

    “remained independently associated with lung cancer status after adjustment [odds ratio (OR) 0.15, 95% confidence interval (CI): 0.02-0.53, P<0.001].”

    Humansadjusted for age, sex, smoking status, and urinary creatinineurinen = 77

    Urinary miR-574-5p as a candidate biomarker for early-stage lung adenocarcinoma: an exploratory case-control study

    Translational lung cancer research

More on miR-574-5p

All-in-tip accelerated proteomics platform

upin humans1

1 study
  1. All-in-tip accelerated proteomics platform predicts lung adenocarcinoma in humans (cancer screening in pilot study) (AUC 0.87-0.89).

    “distinguished malignant from benign pulmonary nodules with areas under the curve (AUC) values of 0.87-0.89”

    Human trialcancer screening in pilot studyplasman = 190

    An All-in-Tip Accelerated Proteomics Platform for Large-Scale Cancer Screening

    Analytical chemistry

More on All-in-tip accelerated proteomics platform

All 18

Trial sponsors

Funding

12 grants since 2020

National Cancer Institute$2.8MOffice of the President, University of California$3.2MUS Department of Veterans Affairs

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 9Feb 2026: 3Mar 2026: 8Apr 2026: 2May 2026: 4Jun 2026: 0Jul 2026: 5Aug 2026: 8Sep 2026: 4Oct 2026: 8Nov 2026: 456 papers in 12 months
medRxiv

Blood-cell mutations linked to two solid cancer subtypes

Solid cancer risk was higher in people with groups of mutated blood cells than in people without them, with a hazard ratio of 1.13.Solid cancer risk was higher in people with groups of mutated blood cells than in people without them, with a hazard ratio of 1.13.

Preprint: cohort studyCancer

See all 155 papers on lung adenocarcinoma